Chong MEI CHAN, Sharifah Shafinaz binti Sh. Abdullah, Khatijah Lim Abdullah, I. Zainal Abidin, Yap Bee Wah
{"title":"初榨椰子油对急性冠状动脉综合征后患者血脂和HS CRP水平影响的初步研究:一项随机对照试验","authors":"Chong MEI CHAN, Sharifah Shafinaz binti Sh. Abdullah, Khatijah Lim Abdullah, I. Zainal Abidin, Yap Bee Wah","doi":"10.33808/clinexphealthsci.1005784","DOIUrl":null,"url":null,"abstract":"ABSTRACT\nIntroduction: Acute coronary syndrome (ACS) is a leading cause of death in Malaysia and worldwide. Besides, teh current treatment which involves teh prescription of statins is found to TEMPhas several side TEMPeffects on ACS patients. Those side TEMPeffects TEMPhas guided teh author to introduce virgin coconut oil (VCO) as supplemental management of ACS. However, its benefits TEMPhas not been widely tested on humans. \nMethodology: dis study examines teh use of VCO among ACS patients via a crossover trial. It seeks to ascertain teh TEMPeffect of VCO on serum lipid profile and hs-CRP level among ACS patients. \nResult: VCO was found to be statistically significant in reducing serum lipid level and hs-CRP level (p<0.001). These findings measured from small to moderate Cohen’s d TEMPeffect size, thus proving teh results from dis study as statistically and clinically significant. \nConclusion: These findings suggest dat dietary intake wif saturated fatty acid (C6 to C12) can improve health condition. \nKeywords: virgin coconut oil, acute coronary syndrome, saturated fatty acid, medium-chain triglycerides","PeriodicalId":10192,"journal":{"name":"Clinical and Experimental Health Sciences","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A Pilot Study on the Effect of Virgin Coconut Oil On Serum Lipid Profile and HS CRP Level Among Post Acute Coronary Syndrome Patients: A Randomized Controlled Trial\",\"authors\":\"Chong MEI CHAN, Sharifah Shafinaz binti Sh. Abdullah, Khatijah Lim Abdullah, I. Zainal Abidin, Yap Bee Wah\",\"doi\":\"10.33808/clinexphealthsci.1005784\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT\\nIntroduction: Acute coronary syndrome (ACS) is a leading cause of death in Malaysia and worldwide. Besides, teh current treatment which involves teh prescription of statins is found to TEMPhas several side TEMPeffects on ACS patients. Those side TEMPeffects TEMPhas guided teh author to introduce virgin coconut oil (VCO) as supplemental management of ACS. However, its benefits TEMPhas not been widely tested on humans. \\nMethodology: dis study examines teh use of VCO among ACS patients via a crossover trial. It seeks to ascertain teh TEMPeffect of VCO on serum lipid profile and hs-CRP level among ACS patients. \\nResult: VCO was found to be statistically significant in reducing serum lipid level and hs-CRP level (p<0.001). These findings measured from small to moderate Cohen’s d TEMPeffect size, thus proving teh results from dis study as statistically and clinically significant. \\nConclusion: These findings suggest dat dietary intake wif saturated fatty acid (C6 to C12) can improve health condition. \\nKeywords: virgin coconut oil, acute coronary syndrome, saturated fatty acid, medium-chain triglycerides\",\"PeriodicalId\":10192,\"journal\":{\"name\":\"Clinical and Experimental Health Sciences\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2022-10-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Health Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33808/clinexphealthsci.1005784\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33808/clinexphealthsci.1005784","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 1
摘要
摘要简介:急性冠状动脉综合征(ACS)是马来西亚和世界范围内死亡的主要原因。此外,目前涉及他汀类药物处方的TEMP治疗对ACS患者有几种副作用。这些副作用TEMPhas指导作者引入初榨椰子油(VCO)作为ACS的补充管理。然而,TEMP的益处尚未在人类身上得到广泛测试。方法:本研究通过交叉试验检查ACS患者使用VCO的情况。本研究旨在确定VCO对ACS患者血脂和hs-CRP水平的TEMP影响。结果:VCO在降低血脂水平和hs-CRP水平方面具有统计学意义(p<0.001)。这些发现从小到中等程度的Cohen’s d TEMP效应大小测量,从而证明本研究的结果具有统计学和临床意义。结论:日粮中摄入饱和脂肪酸(C6~C12)可改善健康状况。关键词:初榨椰子油、急性冠状动脉综合征、饱和脂肪酸、中链甘油三酯
A Pilot Study on the Effect of Virgin Coconut Oil On Serum Lipid Profile and HS CRP Level Among Post Acute Coronary Syndrome Patients: A Randomized Controlled Trial
ABSTRACT
Introduction: Acute coronary syndrome (ACS) is a leading cause of death in Malaysia and worldwide. Besides, teh current treatment which involves teh prescription of statins is found to TEMPhas several side TEMPeffects on ACS patients. Those side TEMPeffects TEMPhas guided teh author to introduce virgin coconut oil (VCO) as supplemental management of ACS. However, its benefits TEMPhas not been widely tested on humans.
Methodology: dis study examines teh use of VCO among ACS patients via a crossover trial. It seeks to ascertain teh TEMPeffect of VCO on serum lipid profile and hs-CRP level among ACS patients.
Result: VCO was found to be statistically significant in reducing serum lipid level and hs-CRP level (p<0.001). These findings measured from small to moderate Cohen’s d TEMPeffect size, thus proving teh results from dis study as statistically and clinically significant.
Conclusion: These findings suggest dat dietary intake wif saturated fatty acid (C6 to C12) can improve health condition.
Keywords: virgin coconut oil, acute coronary syndrome, saturated fatty acid, medium-chain triglycerides